A systematic review identifying seminal plasma biomarkers and their predictive ability on IVF and ICSI outcomes.

Assisted reproductive technology Biomarker ICSI IVF Seminal plasma

Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
18 Oct 2023
Historique:
received: 20 06 2023
revised: 30 06 2023
accepted: 12 10 2023
medline: 22 12 2023
pubmed: 22 12 2023
entrez: 21 12 2023
Statut: aheadofprint

Résumé

The diverse nature and high molecule concentration of seminal plasma (SP) makes this fluid a good potential source for a potential biomarker that could predict assisted reproductive technology (ART) outcomes. Currently, semen quality parameters cannot accurately predict ART outcomes. A systematic literature search was conducted to identify human SP biomarkers with potential predictive ability for the outcomes of IVF and intracytoplasmic sperm injection. Observational cohort and case-control studies describing the association between biomarkers in human SP and the outcome of infertile men attending for ART were included. Forty-three studies were selected, reporting on 89 potential SP biomarkers (grouped as oxidative stress, proteins glycoproteins, metabolites, immune system components, metals and trace elements and nucleic acids). The present review supports 32 molecules in SP as potentially relevant biomarkers for predicting ART outcomes; 23 molecules were reported once and nine molecules were reported in more than one study; IL-18 and TGF-β1-IL-18 ratio were confirmed in distinct studies. This review presents the most comprehensive overview of relevant SP biomarkers to predict ART outcomes to date, which is of clinical interest for infertility investigations and assisted reproduction; nevertheless, its potential is under-exploited. This review could serve as starting point for designing an all-encompassing study for biomarkers in SP and their predictive ability for ART outcomes, and for developing a non-invasive diagnostic tool.

Identifiants

pubmed: 38128376
pii: S1472-6483(23)00721-6
doi: 10.1016/j.rbmo.2023.103622
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103622

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Jonna S van den Berg (JS)

Department of Reproductive Medicine and Gynaecology, Division Female and Baby, University Medical Centre Utrecht, Utrecht, the Netherlands.

Nerea M Molina (NM)

Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.

Signe Altmäe (S)

Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Brigitte Arends (B)

Department of Reproductive Medicine and Gynaecology, Division Female and Baby, University Medical Centre Utrecht, Utrecht, the Netherlands.

Gaby Sarina Steba (GS)

Department of Reproductive Medicine and Gynaecology, Division Female and Baby, University Medical Centre Utrecht, Utrecht, the Netherlands. Electronic address: G.S.Steba@umcutrecht.nl.

Classifications MeSH